Home/ GLPs & Metabolics/ Tirzepatide
Tirzepatide 10mg–60mg research peptide vial — Dual GIP / GLP-1 Agonist

Images are for illustrative purposes only.

GIP / GLP-1

Tirzepatide

Dual GIP / GLP-1 Agonist

Tirzepatide is a dual agonist that activates both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors from a single peptide backbone, making it a common subject in comparative incretin research. Like semaglutide it carries a fatty-acid moiety for albumin binding and a long research half-life.

Preclinical and in vitro studies examine how simultaneous GIP and GLP-1 receptor engagement alters insulin secretion, glucagon dynamics, lipid handling, and appetite signaling relative to single-receptor GLP-1 agonists. The dual-receptor mechanism is the central point of interest and the reason tirzepatide is frequently modeled alongside semaglutide and the triple agonist retatrutide. Supplied as a lyophilized 10-vial kit across 10mg to 60mg sizes for in vitro research use only.

$340
1
$340
per 10-vial kit
$3.40 / mg
Research Library
Tirzepatide Research Review →
Mechanism, evidence level & in vitro context
CategoryGLPs & Metabolics
Purity◆ ≥99%
FormLyophilized powder
Kit size10 vials
Per vial10mg
Storage−20°C recommended
UseResearch only
Certificate of Analysis
Available upon request. Custom and large batch orders include a batch-specific COA.
★  5+ kits, $20 off per kit
★  10+ kits, $30 off per kit
✓  Free shipping over $500 ($30 flat under)
✓  Discreet worldwide shipping in 2–3 business days
✓  Pay with crypto: BTC, USDC & USDT
View Cart → ← Back to GLPs & Metabolics
⚠ For in vitro research use only. Not for human or animal consumption. Not evaluated by the FDA. Read full disclaimer →
Common Questions

Tirzepatide FAQ

What is Tirzepatide?+
Tirzepatide is a Dual GIP / GLP-1 Agonist supplied for laboratory research. Dual GIP and GLP-1 receptor co-agonist investigated in vitro for multi-receptor activation dynamics, insulin secretion pathway modeling, and metabolic signaling research.
Is Tirzepatide the same as Mounjaro and Zepbound?+
Tirzepatide is the dual GIP/GLP-1 receptor agonist studied as the active compound in branded products such as Mounjaro and Zepbound. What is offered here is unformulated tirzepatide for laboratory research only, not an approved medicine.
What is lyophilized Tirzepatide, and how is it reconstituted?+
Tirzepatide is supplied as a lyophilized (freeze-dried) powder, a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently, never shaken, until the powder fully dissolves. All handling is for in vitro research use only.
How should Tirzepatide be stored?+
Store the lyophilized Tirzepatide powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.
What is the purity of Tirzepatide, and how is it tested?+
Every batch of Tirzepatide is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods: high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.
Same Category

Related Compounds

GIP / GLP-1 / GCG
Retatrutide
Triple Receptor Agonist
from $400
 GLP-1
Semaglutide
GLP-1 Receptor Agonist
from $310
 Amylin
Eloralintide
Next-Generation Amylin Analogue
$580